Antitrust Antitrust

Servier, Mylan, Teva spar with EU regulator over patent settlements at bloc's top court

By Nicholas Hirst
  • 20 Oct 2021 12:50
  • 20 Oct 2021 12:50
Les Laboratoires Servier and the European Commission clashed today at the EU's top court over patent settlement deals that prompted hundreds of millions of euros of fines.

The hearing at the EU Court of Justice also involves makers of generic drugs including Mylan, Teva and Lupin.

"Servier, like judges across

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News